BTC Capital Management Inc. decreased its stake in Danaher Co. (NYSE:DHR) by 2.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,503 shares of the conglomerate’s stock after selling 1,364 shares during the period. BTC Capital Management Inc.’s holdings in Danaher were worth $4,317,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. National Asset Management Inc. grew its holdings in Danaher by 0.4% during the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after purchasing an additional 14 shares during the period. Brighton Jones LLC lifted its position in Danaher by 0.4% during the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after acquiring an additional 21 shares during the last quarter. Buckingham Asset Management LLC lifted its position in Danaher by 0.4% during the second quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock worth $488,000 after acquiring an additional 24 shares during the last quarter. Simmons Bank lifted its position in Danaher by 0.4% during the second quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock worth $604,000 after acquiring an additional 26 shares during the last quarter. Finally, Horizon Investments LLC lifted its position in Danaher by 0.4% during the second quarter. Horizon Investments LLC now owns 7,828 shares of the conglomerate’s stock worth $648,000 after acquiring an additional 28 shares during the last quarter. Institutional investors own 75.88% of the company’s stock.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the completion of the sale, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at $23,226,997.80. The disclosure for this sale can be found here. Insiders have sold 274,913 shares of company stock worth $27,729,293 in the last quarter. Company insiders own 12.20% of the company’s stock.
Shares of Danaher Co. (NYSE DHR) opened at $95.41 on Tuesday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. Danaher Co. has a one year low of $78.97 and a one year high of $104.82. The firm has a market cap of $66,370.00, a price-to-earnings ratio of 27.26, a P/E/G ratio of 1.99 and a beta of 1.04.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. Danaher’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.05 earnings per share. analysts forecast that Danaher Co. will post 4.37 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were issued a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. Danaher’s dividend payout ratio is currently 16.00%.
Several brokerages have issued reports on DHR. Argus lifted their price target on shares of Danaher from $100.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Royal Bank of Canada reissued a “hold” rating and issued a $98.00 price objective on shares of Danaher in a research note on Wednesday, January 31st. Stifel Nicolaus lifted their price objective on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Morgan Stanley lifted their price objective on shares of Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research note on Wednesday, January 31st. Finally, Credit Suisse Group lifted their price objective on shares of Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. One analyst has rated the stock with a sell rating, five have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $100.13.
ILLEGAL ACTIVITY NOTICE: “BTC Capital Management Inc. Trims Stake in Danaher Co. (NYSE:DHR)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/13/btc-capital-management-inc-sells-1364-shares-of-danaher-co-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.